(RTTNews) - Cocrystal Pharma, Inc. (COCP), Thursday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988 for the treatment and prophylaxis of norovirus infection.
1 views
Cocrystal Pharma's CDI-988 Secures FDA Fast Track Designation To Prevent And Treat Norovirus
(RTTNews) - Cocrystal Pharma, Inc. (COCP), Thursday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988 for the treatment and prophylaxis of norovirus infection.
